Cubist Systematic Strategies’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Cubist Systematic Strategies’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,144	Closed	-$97K	–	3223
2021 Q1	$97K	Sell	4,144 -14,575	-78%	-$442K	﹤0.01%	2650
2020 Q4	$539K	Sell	18,719 -19,517	-51%	-$491K	0.01%	1736
2020 Q3	$775K	Buy	38,236 +34,897	+1,045%	+$852K	0.01%	1482
2020 Q2	$100K	Sell	3,339 -10,661	-76%	-$384K	﹤0.01%	2193
2020 Q1	$440K	Buy	14,000 +9,864	+238%	+$343K	0.01%	1322
2019 Q4	$195K	Buy	+4,136	New	+$119K	﹤0.01%	2044

Other funds holding CNST

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

OPU

Omni Partners US Irvine, California $1.95B AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

PIM

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cubist Systematic Strategies's CNST Position: Q2 2021 in Review

Cubist Systematic Strategies sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 4,144 shares — an estimated $97K sold.

Cubist Systematic Strategies first reported a position in CNST in Q4 2019 and held it in 6 quarters. The position peaked at $775K in Q3 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

Cubist Systematic Strategies reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Cubist Systematic Strategies sold 4,144 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $97K.
Cubist Systematic Strategies first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 6 quarters.
Cubist Systematic Strategies's Constellation Pharmaceuticals, Inc. position peaked at $775K in Q3 2020.
153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.